Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1994 Feb;102(2):182–184. doi: 10.1289/ehp.94102182

Bioavailability of inorganic arsenic from bog ore-containing soil in the dog.

K Groen 1, H A Vaessen 1, J J Kliest 1, J L de Boer 1, T van Ooik 1, A Timmerman 1, R F Vlug 1
PMCID: PMC1567186  PMID: 8033848

Abstract

In some parts of The Netherlands, bog ore-containing soils predominate, which have natural arsenic levels that exceed, by a factor of 10, existing standards for maximum allowable levels of inorganic arsenic in soil. These standards are based on the assumption that in humans the bioavailability of arsenic from ingested soil is equal to that from an aqueous solution. In view of the regulatory problem that the arsenic levels of these soils present, we questioned the validity of this assumption. To obtain a more realistic estimate, the bioavailability of inorganic arsenic from soil in a suitable animal model was studied. In this report, a study performed in six dogs in a two-way cross-over design is presented. The dogs received orally, in random order, arsenic both as an intravenous solution and as arsenic-containing soil. During a 120-hr period after administration urine was collected in 24-hr fractions. Levels of arsenic were determined using a method of wet digestion, isolation and complexation of arsine, followed by molecule absorption spectrometry. Within 120 hr after intravenous administration, 88 +/- 16% of the dose was excreted renally. After oral administration of arsenic-containing soil, only 7.0 +/- 1.5% was excreted renally. From the urinary excretion data for these two routes of administration, the calculated bioavailability of inorganic arsenic from soil was 8.3 +/- 2.0%. The results from this study demonstrate the need to reconsider the present risk assessment for arsenic in soil.

Full text

PDF
182

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Charbonneau S. M., Spencer K., Bryce F., Sandi E. Arsenic excretion by monkeys dosed with arsenic-containing fish or with inorganic arsenic. Bull Environ Contam Toxicol. 1978 Oct;20(4):470–477. doi: 10.1007/BF01683551. [DOI] [PubMed] [Google Scholar]
  2. Johnson L. R., Farmer J. G. Use of human metabolic studies and urinary arsenic speciation in assessing arsenic exposure. Bull Environ Contam Toxicol. 1991 Jan;46(1):53–61. doi: 10.1007/BF01688254. [DOI] [PubMed] [Google Scholar]
  3. Marafante E., Rade J., Sabbioni E., Bertolero F., Foà V. Intracellular interaction and metabolic fate of arsenite in the rabbit. Clin Toxicol. 1981 Nov;18(11):1335–1341. doi: 10.3109/00099308109035074. [DOI] [PubMed] [Google Scholar]
  4. Pomroy C., Charbonneau S. M., McCullough R. S., Tam G. K. Human retention studies with 74As. Toxicol Appl Pharmacol. 1980 May;53(3):550–556. doi: 10.1016/0041-008x(80)90368-3. [DOI] [PubMed] [Google Scholar]
  5. Vaessen H. A., van Ooik A., van de Kamp C. G. Some elements in domestic and imported fresh fruits marketed in The Netherlands. Z Lebensm Unters Forsch. 1991 Oct;193(4):351–355. doi: 10.1007/BF01191633. [DOI] [PubMed] [Google Scholar]
  6. Woolson E. A. Fate of arsenicals in different environmental substrates. Environ Health Perspect. 1977 Aug;19:73–81. doi: 10.1289/ehp.771973. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES